Metformin and N-terminal pro B-type natriuretic peptide in type 2 diabetes patients, a post-hoc analysis of a randomized controlled trial

• Wiebe M. C. Top,

  Roles Formal analysis, Writing – original draft

  Affiliations Department of Internal Medicine, Care Group Treant, Location Bethesda Hoogeveen, Hoogeveen, The Netherlands, Bethesda Diabetes Research Center, Hoogeveen, The Netherlands

  https://orcid.org/0000-0001-5192-6805

  ⨯
• Philippe Lehert,

  Roles Formal analysis

  Affiliation Department of Statistics, Faculty of Economics, Facultés Universitaires Catholiques de Mons, Louvain Academy, Mons, Belgium

  ⨯
• Casper G. Schalkwijk,

  Roles Investigation

  Affiliation Department of Internal Medicine and Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands

  ⨯
• Coen D. A. Stehouwer,

  Roles Conceptualization, Writing – review & editing

  Affiliation Department of Internal Medicine and Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands

  ⨯
• Adriaan Kooy

  Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing

  * E-mail: a.kooy@treant.nl

  Affiliations Department of Internal Medicine, Care Group Treant, Location Bethesda Hoogeveen, Hoogeveen, The Netherlands, Bethesda Diabetes Research Center, Hoogeveen, The Netherlands, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

  ⨯